3-(2-Chloropyrimidin-4-yl)-1-Methyl-1H-Indole (CAS No: 1032452-86-0) in Osimertinib Intermediates | VidgasTech
Introduction
The advancement of pharmaceutical chemistry has brought forward several innovative compounds that play a critical role in modern drug synthesis. One such compound is 3-(2-Chloropyrimidin-4-yl)-1-Methyl-1H-Indole (CAS No: 1032452-86-0) — a vital intermediate in the preparation of Osimertinib, a targeted therapy used in the treatment of non-small cell lung cancer (NSCLC).
At VidgasTech, we specialize in the manufacturing and global supply of high-quality Osimertinib intermediates and other fine chemicals that meet stringent quality and regulatory standards.
About 3-(2-Chloropyrimidin-4-yl)-1-Methyl-1H-Indole
Chemical Name: 3-(2-Chloropyrimidin-4-yl)-1-Methyl-1H-Indole CAS Number: 1032452-86-0 Molecular Formula: C₁₃H₁₀ClN₃ Molecular Weight: 243.69 g/mol
This compound is one of the key intermediates required in the multi-step synthesis of Osimertinib, an EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor that specifically targets mutations associated with lung cancer resistance.
Role in Osimertinib Synthesis
Osimertinib, also known by the trade name Tagrisso, is a third-generation EGFR inhibitor developed to overcome resistance mutations such as T790M. 3-(2-Chloropyrimidin-4-yl)-1-Methyl-1H-Indole acts as a crucial building block that contributes to the molecular structure of Osimertinib, enhancing its selectivity and potency against mutated EGFR enzymes.
This intermediate ensures synthetic efficiency and chemical stability, making it an essential part of the drug manufacturing process.
Applications
Pharmaceutical R&D: Used in the research and development of EGFR inhibitor-based therapies.
Commercial Drug Manufacturing: Serves as a key intermediate in the large-scale synthesis of Osimertinib.
Oncology Research: Supports ongoing research in targeted cancer treatments.
VidgasTech – Trusted Source for Osimertinib Intermediates
At VidgasTech, we focus on precision chemistry and quality consistency. Our manufacturing infrastructure and experienced scientific team allow us to produce 3-(2-Chloropyrimidin-4-yl)-1-Methyl-1H-Indole and other related intermediates with high purity and reproducibility.
We ensure:
✅ Stringent quality control and analytical testing
✅ Customized synthesis based on client requirements
✅ Timely delivery and global export support
✅ Compliance with international regulatory standards
Our mission is to empower pharmaceutical companies with reliable intermediates that accelerate innovation in cancer treatment and other therapeutic areas.
Why Choose VidgasTech?
Leading manufacturer and supplier of pharmaceutical intermediates
Expertise in EGFR inhibitor chemistry and oncology intermediates
Commitment to sustainability, quality, and innovation
Strong R&D capabilities with continuous process improvement
Conclusion
3-(2-Chloropyrimidin-4-yl)-1-Methyl-1H-Indole (CAS 1032452-86-0) plays a pivotal role in the development of Osimertinib, a breakthrough in lung cancer therapy. With a strong emphasis on quality and reliability, VidgasTech continues to be a trusted partner for pharmaceutical manufacturers and research institutions worldwide.
For more details or bulk inquiries about Osimertinib intermediates, contact VidgasTech today.
Contact Information
🌐 Website: https://www.vidgastech.com












